Fact-checked by Grok 2 weeks ago

Lignoceric acid

Lignoceric acid, also known as tetracosanoic acid, is a saturated very long-chain fatty acid characterized by a 24-carbon backbone and the molecular formula C24H48O2, with a molecular weight of 368.64 g/mol. It features a linear structure represented as CH3(CH2)22COOH, and exhibits physical properties including a melting point of 80–82 °C, a boiling point of approximately 406 °C, and a density of about 0.9 g/cm³. Naturally occurring in sources such as wood tar, plant lipids, and small amounts in dietary fats like those from peanuts and olives, lignoceric acid is synthesized in mammals during brain development and serves as a key component of cerebrosides, which are essential lipids in the myelin sheath of nerve tissues. In biological systems, lignoceric acid plays a critical role in myelination, where it is incorporated into cerebrosides and can undergo alpha-hydroxylation to form cerebronic acid, contributing to the structural integrity and function of myelin lipids in both central and peripheral nervous systems. Its activation via acyl-CoA synthetases is implicated in cerebroside synthesis, supporting nerve conduction and maintenance. As a human metabolite and plant-derived compound, lignoceric acid is present in trace amounts in various foods and has been studied for its involvement in metabolic pathways, though it is not considered an essential fatty acid.

Chemical identity

Nomenclature and structure

Lignoceric acid is the common name for tetracosanoic acid, a straight-chain saturated consisting of a 24-carbon chain attached to a group. The name "lignoceric" derives from the Latin lignum (meaning "wood") and kēros (meaning "wax"), reflecting its initial isolation from wood , although it is not directly related to . This was first identified in the late through the of or rotten wood . The molecular formula of lignoceric acid is C_{24}H_{48}O_2, and its is CH_3(CH_2)_{22}COOH, highlighting the unbranched alkyl chain with no double bonds. Under the International Union of Pure and Applied Chemistry (IUPAC) for carboxylic acids, it is systematically named tetracosanoic acid, where "tetracos" refers to the 24-carbon chain derived from the parent tetracosane (C_{24}H_{50}), with the suffix "-oic acid" indicating the carboxyl group at carbon 1. This standardizes fatty acids as alkanoic acids based on chain length and saturation. Lignoceric acid is classified as a very long-chain (VLCFA) due to its carbon atoms, surpassing the typical boundary of carbons that distinguishes VLCFAs from long-chain fatty acids (12– carbons). This categorization is important in biochemistry, as VLCFAs like lignoceric acid play specialized roles in cellular membranes, though such functions are beyond the scope of its .

Physical properties

Lignoceric acid appears as a to off-white crystalline solid at . Its melting point is approximately 84–86 °C. The boiling point is reported as 272 °C at 10 mm Hg pressure. Lignoceric acid is insoluble in water, with a solubility of approximately 5.93 × 10^{-6} mg/L at 25 °C, but it is soluble in organic solvents such as chloroform, ethanol, ethyl acetate (slightly when heated), and diethyl ether. The of lignoceric acid is about 0.879 g/cm³. Its molecular weight is 368.64 g/mol. In , lignoceric acid exhibits a characteristic carbonyl absorption band at approximately 1710 cm⁻¹, typical of saturated carboxylic acids. For , the ^ NMR spectrum shows signals for the long alkyl chain, including a terminal at around 0.9 , methylene protons at 1.2–1.3 , and the alpha-methylene to the carboxyl at about 2.3 .

Sources and biosynthesis

Natural occurrence

Lignoceric acid occurs naturally in small amounts across various biological materials, primarily as a saturated very long-chain (VLCFA) component of . In , it is present in waxes such as , where it contributes to the free fraction alongside cerotic and montanic acids. Similarly, from the leaves of Copernicia prunifera contains lignoceric acid at concentrations up to approximately 30% of its content. It is also found in wood extractives and fractions derived from coniferous trees, often as a associated with processing. In animal tissues, lignoceric acid is notably enriched in lipids, particularly within sphingomyelins of tissue, where it typically comprises 1–5% of the fatty acids, though VLCFAs as a group can reach up to 40% in certain myelin-related fractions. The overall concentration in tissue averages 6–7 μmol/g, with higher levels in the compared to the medulla. Traces are reported in other animal fats and in microbial lipids, including those from , seaweeds, and certain fungi, though often at low or undetectable levels in thermophilic species. In , concentrations range from 1.1% to 2.2% of total fatty acids. As a minor VLCFA, lignoceric acid is evolutionarily conserved across eukaryotes, reflecting its incorporation into that are ubiquitous in eukaryotic membranes. Its identification in natural samples commonly relies on gas chromatography-mass spectrometry (GC-MS), which enables precise quantification after derivatization to fatty acid methyl esters.

Biosynthetic pathways

Lignoceric acid, a saturated very long-chain (VLCFA) with 24 carbon atoms (C24:0), is biosynthesized through iterative elongation of shorter-chain fatty acids, primarily starting from (C16:0) in both animals and . In mammals, this process occurs in the (ER) and involves a multi-enzymatic cycle that adds two-carbon units to the acyl chain. The key rate-limiting enzyme is the elongase ELOVL1, which preferentially elongates saturated and monounsaturated acyl-CoAs from C20 to C26, including the production of C24:0-CoA essential for synthesis. ELOVL3 also contributes by elongating C16–C22 acyl-CoAs, supporting the stepwise extension toward C24:0. The elongation cycle consists of four sequential steps: (1) condensation of acyl-CoA with malonyl-CoA to form β-ketoacyl-CoA, catalyzed by ELOVL enzymes; (2) reduction of the β-keto group to β-hydroxyacyl-CoA using NADPH, mediated by β-ketoacyl-CoA reductase (KAR); (3) dehydration to form trans-2-enoyl-CoA by 3-hydroxyacyl-CoA dehydratase (HACD); and (4) a second NADPH-dependent reduction to yield the elongated acyl-CoA, catalyzed by trans-2-enoyl-CoA reductase (TER). The net reaction for one cycle of elongation can be outlined as: \text{R-CH}_2\text{-CH}_2\text{-CO-SCoA} + \text{malonyl-CoA} + 2\text{ NADPH} \rightarrow \text{R-(CH}_2\text{)}_4\text{-CO-SCoA} + \text{CO}_2 + 2\text{ NADP}^+ This cycle repeats multiple times (typically four iterations from C16:0 to reach C24:0), with malonyl-CoA serving as the two-carbon donor derived from acetyl-CoA carboxylation. Regulation of lignoceric acid biosynthesis is influenced by the ER localization of the elongase complex, where enzyme activity is coordinated with downstream ceramide synthases (e.g., CERS2 for C24 sphingolipids) to match cellular demand, particularly in tissues like the brain where VLCFAs are enriched. In plants, the pathway shares similarities but utilizes a distinct set of ER-bound enzymes from the 3-ketoacyl-CoA synthase (KCS) family, such as KCS2 and KCS20, which elongate C16:0 or C18:0 precursors to C24:0 for incorporation into cuticular waxes, suberins, and sphingolipids; Arabidopsis possesses 21 KCS isoforms enabling greater chain-length diversity (up to C38) compared to the seven ELOVLs in mammals, reflecting adaptations for extracellular barrier functions rather than primarily membrane sphingolipids.

Biochemical roles

In sphingolipids

Lignoceric acid functions as a primary component in , where it is attached via an linkage to the backbone of , forming structures such as sphingomyelins and . This integration is particularly evident in kerasin, a type of that incorporates lignoceric acid as its defining acyl chain. By esterifying to the core, lignoceric acid enhances the stability of the sheath in , supporting the insulation of nerve fibers essential for efficient . The extended 24-carbon chain of lignoceric acid imparts significant structural effects on sphingolipid-containing membranes, increasing their rigidity and elevating the gel-to-liquid crystalline temperature. These properties arise from stronger van der Waals interactions among the saturated, very long-chain fatty acyl groups, which promote tighter packing in bilayers and contribute to the compact, multilayered architecture of . In human brain sphingolipids, lignoceric acid is a major constituent of very long-chain fatty acids, with prominent occurrence in galactocerebrosides of nervous tissue. This composition underscores its role in maintaining myelin integrity; deficiencies or dysregulation in pathways involving lignoceric acid incorporation, such as those affected by mutations in peroxisomal transport genes, are linked to leukodystrophies that impair nerve insulation. Recent studies as of 2024 have also linked circulating levels of very long-chain saturated fatty acids, including lignoceric acid, to cognitive function and potential roles in neurodegenerative diseases.

Metabolism and degradation

Lignoceric acid, a very long-chain (VLCFA), undergoes activation to lignoceroyl-CoA prior to beta-oxidation, primarily catalyzed by lignoceroyl-CoA enzymes located in peroxisomes and the , with lower activity in mitochondria. This activation step is essential for subsequent oxidative processing. In peroxisomal disorders like X-linked (X-ALD), transport of lignoceroyl-CoA into peroxisomes is defective due to mutations in the ABCD1 gene, leading to impaired oxidation despite preserved ligase activity. Degradation of lignoceroyl-CoA occurs predominantly in peroxisomes, where initial rounds of beta-oxidation shorten the chain length through successive removal of two-carbon units, producing hydrogen peroxide as a byproduct via the action of acyl-CoA oxidase. Once shortened to medium- or long-chain lengths (typically C16-C18), the resulting acyl-CoAs are transferred to mitochondria for complete beta-oxidation to generate energy via the electron transport chain. This compartmentalized process ensures efficient handling of VLCFAs, which cannot be fully oxidized in mitochondria alone due to their length. Defects in peroxisomal beta-oxidation of lignoceric acid are central to disorders like X-linked adrenoleukodystrophy (X-ALD), caused by mutations in the ABCD1 gene encoding the ALDP protein, which transports VLCFA-CoAs into peroxisomes for oxidation. In X-ALD, oxidation rates for lignoceric acid are reduced to 38% of normal, leading to VLCFA accumulation in tissues and bodily fluids. Similarly, peroxisomal oxidation is severely impaired in Zellweger syndrome due to the absence of functional peroxisomes, with rates as low as 1.8% of controls, highlighting the organelle's exclusive role in initial VLCFA degradation. In normal , lignoceric acid is largely fully oxidized for , with minor urinary as shortened metabolites or conjugates, though specific profiles are limited and elevated in peroxisomal disorders. Its metabolism is regulated by dietary fat intake, which can induce peroxisomal enzyme expression via peroxisome proliferator-activated receptor alpha (PPARα), and hormonal signals such as those from liver X receptor alpha (LXRα), which modulates hepatic peroxisomal beta-oxidation activity.

Applications and research

Industrial uses

Lignoceric acid is primarily extracted from natural sources such as beechwood tar or through of rotten oak wood, where it occurs as a minor component in lignocellulosic materials. Industrial purification involves isolating it from these mixtures via solvent extraction or processes to achieve high purity for commercial use. Alternatively, it can be obtained as a from the processing of or plant waxes like sugar cane wax, which contain lignoceric alcohol as a precursor. A key industrial synthesis method involves the oxidation of lignoceric alcohol-rich mixtures derived from synthetic fatty alcohols (produced via oxidation) or natural waxes, using a quaternary ammonium peroxotungstophosphate catalyst and at 90-120°C, followed by , , and acidification to yield the acid. This process enables bulk from abundant raw materials, though it is not yet widely commercialized on a large scale. No established industrial routes from unsaturated C24 precursors have been documented for lignoceric acid . In cosmetics, lignoceric acid serves as an emollient and softener in creams, dermal oils, and hair conditioners, leveraging its long-chain structure to provide moisturizing and conditioning properties that enhance skin barrier function and reduce water loss. It also functions as a surfactant and material processing agent in formulations for detergents and coatings, contributing to emulsification and stability due to its hydrophobic nature. Additionally, it finds use as a component in adhesives and indirect food additives, where its fatty acid profile aids in binding and protective layering. Lignoceric acid plays a minor role in the fatty acid mixtures used for soaps and high-performance lubricants, where its chain length imparts viscosity control and wear reduction, though it constitutes a small fraction of overall production volumes in these sectors. Its low natural abundance limits widespread adoption, with applications confined to niche, high-value products rather than bulk commodities.

Health and medical implications

Lignoceric acid, a very long-chain saturated (VLCFA), accumulates in patients with X-linked (X-ALD) due to mutations in the ABCD1 gene, which impair peroxisomal beta-oxidation of VLCFAs with chain lengths of 22 carbons or more. This accumulation, including elevated levels of lignoceric acid (C24:0), disrupts mitochondrial function, elevates (ROS), and deregulates calcium homeostasis, contributing to neurotoxicity particularly in and leading to progressive demyelination of the . In infantile , a peroxisomal disorder primarily characterized by accumulation, defective beta-oxidation pathways also result in elevated VLCFAs such as lignoceric acid, exacerbating brain through similar mechanisms of and mitochondrial impairment, which promote neuronal damage and . Dietary intake of lignoceric acid is generally low, as it occurs in trace amounts in foods such as and , contributing minimally to overall consumption compared to shorter-chain fats. In the context of neurological support, particularly for demyelinating conditions like X-ALD, therapeutic diets incorporating related unsaturated VLCFAs (e.g., ) have been explored to modulate VLCFA levels and potentially mitigate disease progression, though direct supplementation with lignoceric acid remains uncommon. Research on lignoceric acid's role in myelin repair has focused on its incorporation into lipids, with studies indicating that VLCFAs like lignoceric acid and its monounsaturated analog (C24:1) are essential for maturation and sheath synthesis. In vitro investigations from the 2010s have shown that esters enhance production in human by promoting lipid synthesis pathways, suggesting potential for analogs in repairing demyelination, though clinical trials specifically targeting lignoceric acid derivatives are limited. Antioxidant effects of lignoceric acid have not been extensively documented , but related long-chain fatty acids demonstrate capacity to reduce in cellular models, warranting further exploration for neuroprotective applications. Elevated levels of lignoceric acid have been observed in patients with psoriatic arthritis, associating with metabolic syndrome and systemic inflammation. Lignoceric acid exhibits low acute toxicity at physiological levels, with animal studies on similar saturated fatty acids reporting oral LD50 values exceeding 5 g/kg body weight, indicating general safety in dietary contexts. However, pathological accumulation of lignoceric acid, as seen in peroxisomal disorders, induces neurotoxicity through mitochondrial dysfunction and ROS-mediated cell death, highlighting the importance of metabolic balance for neurological health.

References

  1. [1]
    Tetracosanoic Acid
    Insufficient relevant content. The provided text only includes a PubChem page header with a logo and a JavaScript requirement notice, lacking specific details about Lignoceric acid (Tetracosanoic Acid | CID 11197). No synonyms, chemical formula, molecular weight, structure, properties, biological occurrence, natural sources, or medical significance are present.
  2. [2]
    Lignoceric acid | CAS#:557-59-5 | Chemsrc
    Aug 22, 2025 · Molecular Weight, 368.637 ; Density, 0.9±0.1 g/cm3 ; Boiling Point, 405.9±8.0 °C at 760 mmHg ; Molecular Formula, C24H48O ; Melting Point, 80-82 °C.
  3. [3]
    Structure Database (LMSD) - LIPID MAPS
    Lignoceric acid is a 24-carbon saturated (24:0) fatty acid. In mammals, it is synthesized during brain development and is found in cerebrosides.
  4. [4]
    Alpha hydroxylation of lignoceric acid to cerebronic acid ... - PubMed
    Aug 10, 1975 · These results suggest a close association of the synthesis of cerebronic acid with the synthesis of the characteristic myelin lipid that is ...
  5. [5]
    Long-chain and very long-chain fatty acyl-coa synthetase activity in ...
    The implication of these findings and the involvement of lignoceric acid activation in cerebroside synthesis is discussed.
  6. [6]
    Lignoceric Acid - an overview | ScienceDirect Topics
    Lignoceric acid is a long-chain fatty acid with more than 12 carbon atoms, found in dietary triglycerides, and involved in metabolic processes.
  7. [7]
    Tetracosanoic Acid
    **Summary of Tetracosanoic Acid (CID 11197) from PubChem**
  8. [8]
    Lignoceric Acid - an overview | ScienceDirect Topics
    Lignoceric acid is defined as a very long-chain saturated fatty acid characterized by a 24-carbon chain length (C24:0) and can be sourced from various foods, ...
  9. [9]
    Very long chain fatty acids - PubMed
    Jul 7, 2022 · VLCFAs, or very long chain polyunsaturated fatty acids (VLCPUFAs), can be defined as fatty acids with 23 or more carbon atoms in the molecule.
  10. [10]
  11. [11]
    Lignoceric Acid 557-59-5 - TCI Chemicals
    Lignoceric Acid. Chemical Structure of Lignoceric Acid. Thumbnail of Lignoceric ... Solubility (soluble in), Chloroform. Safety & Regulations plus. GHS ...
  12. [12]
    lignoceric acid, 557-59-5
    Molecular Weight: 368.64496000. Formula: C24 H48 O2. BioActivity Summary: listing. NMR Predictor: Predict (works with chrome, Edge or firefox). Category ...Missing: biological sources
  13. [13]
    LIGNOCERIC ACID | 557-59-5 - ChemicalBook
    Oct 29, 2025 · Chemical Name: LIGNOCERIC ACID ; CBNumber: CB9333161 ; Molecular Formula: C24H48O2 ; Molecular Weight: 368.64 ; MDL Number: MFCD00002810.Missing: physical | Show results with:physical
  14. [14]
    LIGNOCERIC ACID CAS#: 557-59-5 - ChemicalBook
    LIGNOCERIC ACID ; storage temp. 2-8°C ; solubility, Chloroform (Slightly, Heated), Ethyl Acetate (Slightly) ; form, Shiny Crystalline Powder or Flakes ; pka, 4.78± ...
  15. [15]
    Lignoceric Acid | CAS NO.:557-59-5 - GlpBio
    Rating 5.0 (9) Lignoceric acid is a 24-carbon saturated (24:0) fatty acid. In mammals, it is synthesized during brain development and is found in cerebrosides.<|control11|><|separator|>
  16. [16]
    LIGNOCERIC ACID(557-59-5) IR Spectrum - ChemicalBook
    ChemicalBook Provide LIGNOCERIC ACID(557-59-5) IR,IR2,MS,IR3,IR,1H NMR,Raman,ESR,13C NMR,Spectrum.Missing: NMR | Show results with:NMR
  17. [17]
    [PDF] The role of fatty acids in the mechanical properties of beeswax - HAL
    Addition of stearic acid to beeswax enhances all of ... while palmitoleic acid, linoleic acid, linolenic acid, and lignoceric acid do vary significantly.
  18. [18]
    US8791281B2 - Method for the production of lignoceric acid
    ... lignoceric acid, such as e.g. carnauba wax (30%) and rice bran wax (40%). A potential source that could be eventually used for production of lignoceric acid ...
  19. [19]
    Analysis of Lignoceric Acid - Celignis
    Lignoceric acid is found in wood extractives and tall oil fractions of coniferous trees. Usually, it is present at trace amounts in microalgae and seaweeds.
  20. [20]
    Lignoceric Acid - an overview | ScienceDirect Topics
    Lignoceric Acid is a saturated very long-chain fatty acid, specifically lignoceric acid (C24:0), that is abundantly found in myelinated peripheral nerve tissues ...
  21. [21]
    Very long-chain fatty acids: elongation, physiology and related ...
    Sep 14, 2012 · Very long-chain fatty acids (VLCFAs) are fatty acids (FAs) with a chain-length of ≥22 carbons. Mammals have a variety of VLCFAs differing in ...
  22. [22]
    Gas chromatography-mass spectrometry-based analytical strategies ...
    This article reviewed the GC-MS-based methods used for fatty acid analysis in terms of their sample preparation methods, column selection, and recent ...
  23. [23]
    Metabolism of Very Long-Chain Fatty Acids: Genes and ... - NIH
    VLCFAs play multiple roles not substituted by LCFAs. KO mice for VLCFA-related genes exhibit various phenotypes, and mutations in VLCFA-related genes cause ...
  24. [24]
    ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid ...
    ELOVL1 activity is regulated with the ceramide synthase CERS2, an enzyme essential for C24 sphingolipid synthesis.
  25. [25]
    Biosynthesis and Functions of Very-Long-Chain Fatty Acids in the ...
    Very-long-chain fatty acids are simply defined as fatty acids with more than 18 carbon atoms, but the lengths of the acyl-chain, its unsaturation degree and ...
  26. [26]
    Absorption of I-I4C Lignoceric Acid in the Rat | Nature
    LIGNOCERIC acid, the straight-chain fatty acid having 24 carbon atoms, is a constituent of the sphingolipids where it is found in amide linkage with sphingosine ...
  27. [27]
    Cerebroside - an overview | ScienceDirect Topics
    The cerebrosides containing lignoceric acid are called kerasin, while those having cerebronic acid are known as phrenosin. Figure 5.11. Schematic ...
  28. [28]
    C24:0 and C24:1 sphingolipids in cholesterol-containing, five - Nature
    Aug 24, 2020 · Results point to C24:0 sphingolipids, namely lignoceroyl sphingomyelin (lSM) and lignoceroyl ceramide (lCer), having higher membrane rigidifying properties.
  29. [29]
    Long chain ceramides raise the main phase transition of ... - Nature
    Dec 2, 2022 · CerS1 exclusively uses long chain 18 carbon fatty acid, forming C18-ceramide. ... In other words, increasing the temperature reduces the rigidity ...
  30. [30]
    Long N-acyl fatty acids on sphingolipids are responsible for ...
    The results are discussed with reference to the role of the length of the N-acyl substituent of the sphingolipids in formation of complexes with phospholipids.
  31. [31]
    Carrier identification of X‐linked adrenoleukodystrophy by ...
    Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation ... Spectrum of mutations in ...
  32. [32]
    impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ...
    May 1, 1989 · However, in cellular homogenates from X-ALD cells, lignoceric acid is oxidized at a rate of 38% of control cells. Therefore, to identify the ...
  33. [33]
    Hepatic Peroxisomal Fatty Acid β-Oxidation Is Regulated by Liver X ...
    Peroxisomes are the exclusive site for the β-oxidation of very-long-chain fatty acids of more than 20 carbons in length (VLCFAs). Although the bulk of diet.
  34. [34]
    X-linked adrenoleukodystrophy (X-ALD): clinical presentation and ...
    Aug 13, 2012 · X-ALD is a metabolic disorder characterized by impaired peroxisomal beta-oxidation of very long-chain fatty acids (VLCFA; ≥ C22), which is reduced to about 30% ...
  35. [35]
    Lignoceric acid is oxidized in the peroxisome - PubMed - NIH
    Lignoceric acid is oxidized in the peroxisome: implications for the Zellweger cerebro-hepato-renal syndrome and adrenoleukodystrophy ... Proc Natl Acad Sci U S A.
  36. [36]
    Brain Lipotoxicity of Phytanic Acid and Very Long-chain Fatty Acids ...
    In the Refsum disease, phytanic acid accumulates throughout the body as a consequence of mutations in two genes, PHYH (the gene encoding the phytanoyl-CoA ...
  37. [37]
    Accumulation and defective beta-oxidation of very long chain fatty ...
    Residual lignoceric acid beta-oxidation activity varied from approximately 15% in Zellweger syndrome up to 50% in X-linked adrenoleukodystrophy. It is ...
  38. [38]
    Lignoceric Acid - an overview | ScienceDirect Topics
    Lignoceric acid is a fatty acid found in olive oil, and may be derived from diets rich in peanut oil. It is a long chain fatty acid with 24 carbon atoms.
  39. [39]
    Dietary erucic acid therapy for X‐linked adrenoleukodystrophy
    We conclude that dietary erucic acid therapy is effective in lowering plasma C26:0 to normal in ALD patients, and may prevent further demyelination in some ...Missing: lignoceric | Show results with:lignoceric
  40. [40]
    Naturally Occurring Nervonic Acid Ester Improves Myelin Synthesis ...
    Jul 29, 2019 · We propose that the intake of FOM rich in the nervonic acid ester may improve OL function, affecting OPC maturation and limiting inflammation.
  41. [41]
    Naturally Occurring Nervonic Acid Ester Improves Myelin Synthesis ...
    Jul 26, 2019 · NA (C24:1) and lignoceric acid (C24:0) are major fatty acids required for myelin synthesis [8, 27]. As discussed below, several lines of ...
  42. [42]
    [PDF] Safety Assessment of Fatty Acids & Fatty Acid Salts as Used in ...
    Nov 9, 2018 · This safety assessment was initiated based on the high frequency of use of Linoleic Acid reported to the VCRP in 2016/2017, which led to its.Missing: lignoceric | Show results with:lignoceric
  43. [43]
    Toxic effects of X-linked adrenoleukodystrophy-associated, very ...
    We suggest that there is a potent toxic activity of VLCFA due to dramatic cell physiological effects with mitochondrial dysfunction and Ca 2+ deregulation.